Uniform DNA distribution in tumors is a prerequisite step for high transfection efficiency in solid tumors. To improve the transfection efficiency of electrically assisted gene delivery to solid tumors in vivo, we explored how tumor histological properties affected transfection efficiency. In four different tumor types (B16F1, EAT, SA-1 and LPB), proteoglycan and collagen content was morphometrically analyzed, and cell size and cell density were determined in paraffin-embedded tumor sections under a transmission microscope. To demonstrate the influence of the histological properties of solid tumors on electrically assisted gene delivery, the correlation between histological properties and transfection efficiency with regard to the time interval between DNA injection and electroporation was determined. Our data demonstrate that soft tumors with larger spherical cells, low proteoglycan and collagen content, and low cell density are more effectively transfected (B16F1 and EAT) than rigid tumors with high proteoglycan and collagen content, small spindle-shaped cells and high cell density (LPB and SA-1). Furthermore, an optimal time interval for increased transfection exists only in soft tumors, this being in the range of 5-15 min. Therefore, knowledge about the histology of tumors is important in planning electrogene therapy with respect to the time interval between DNA injection and electroporation.
Introduction
The potential for using genetic technology to treat human diseases (i.e., gene therapy) is receiving considerable attention at present; it is significantly promising as an adjuvant therapeutic mode for cancer treatment. However, many challenging obstacles have also arisen from the use of genetic materials as therapeutic agents. One important challenge in cancer gene therapy is to identify the fragilities of cancers as unique biological systems and to develop a delivery system that is specific, safe and efficient. Different delivery systems have been developed; in general these are divided into viral and non-viral vectors. The latter are favored over the former, due to their simplicity and lack of specific immune response stimulation. However, they are limited by their lower gene transfer efficiency compared with viral vectors. Therefore different non-viral gene delivery methods have been developed, including the injection of naked DNA, protein-DNA complexes, liposomes and their analogs, and delivery by 'gene gun' or electroporation, as well as various combinations of these methods. 1 Plasmid DNA injection and subsequent electroporation of tumor tissue is one of the most promising non-viral delivery systems for use in clinical gene therapy for cancer. 2, 3 It is a physical method of gene delivery that facilitates the uptake of DNA into target cells by increasing the transmembrane potential above a certain threshold.
Although many studies employing non-viral gene delivery systems have been shown to efficiently deliver DNA to tumor cells in vitro, 4, 5 only a minority of them were capable of achieving sufficient in vivo gene transfer to tumor tissue. [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] Moreover, studies on different tumor types using the same delivery system have shown different transfection efficiencies. [6] [7] [8] [9] [10] There is a substantial amount of literature explaining variable transfection efficiencies in vitro as well as in vivo due to variations in optimal experimental conditions, therapeutic genes, plasmid DNA backbone and mice age, [16] [17] [18] whereas the results of only a few studies performed on tumors in vivo and on tumor spheroids have drawn attention to tumor microenvironment and to the problems related to transport of DNA through the tumor tissue. [19] [20] [21] Therefore, as compared with methodological factors, specific tumor properties may have equal or greater influence on transfection efficiency in tumors. Further supporting this hypothesis are preclinical and clinical studies on anticancer drug penetration through tumor tissue.
Limited penetration of anticancer drugs through tumor tissue has been proposed as a potential cause of resistance of solid tumors to anticancer drugs. 22, 24, 26 These kinds of studies lead to novel treatment strategies that might improve the cell kill by enhancing drug penetration through the tumor tissue.
Compared to anticancer drugs, diffusion, distribution, degradation and uptake of DNA into tumor cells in tumor tissue has been investigated to a much smaller extent. There are a few in vivo reports showing that delivery of macromolecules such as genes or antibodies to cells in tumors is affected by the amount of DNases, which degrade exogenous DNA, by necrosis and macrophage infiltration, 19 as well as by increased interstitial fluid pressure 27 and the amount of extracellular matrix components, such as collagen 28, 29 and hyaluronan. 30 On the other hand, in vitro studies have exposed the effect of the shape, size and orientation of cells in tissue and cell density. 31, 32 Therefore, an important challenge for efficient gene therapy in solid tumors is to identify the structural and physiological properties of the tumor tissue. Better understanding of tissue barriers might be useful for the prediction of transgene expression patterns in certain tumor types in vivo, as well as for further optimization of gene delivery systems.
Therefore, the aim of our study was to determine the effect of the histological properties of solid tumors on the transfection efficiency of electrically assisted gene delivery. The emphasis was on microscopic analysis of tumor tissue, determining cell size, cell density and the amount of extracellular matrix components, proteoglycans and collagen. To demonstrate the influence of the histological properties of solid tumors on electrically assisted gene delivery, the correlation between histological properties and transfection efficiency with regard to the time interval between DNA injection and electroporation was determined.
Results

Histological properties of tumors
On the macroscopic level, morphological differences were found between B16F1, EAT, SA-1 and LPB tumors. The B16F1 melanoma tumors appeared very soft and pulpous. SA-1 and LPB fibrosarcomas were solid and rigid, whereas EAT mammary carcinoma tumors fell between melanoma and fibrosarcoma tumors as regards tissue consistency. The histological properties of these tumors were examined by the determination of cell density, cell size, and amount of extracellular matrix components, proteoglycans and collagen. For each tumor type, 18 microscopic fields, obtained from six tumor samples and three fields of view per tumor section, were analyzed. Tumor sections were stained with hematoxylineosin (H&E) for the determination of cell density and cell size. Periodic acid-Schiff (PAS) staining was performed to visualize the proteoglycan content, and Masson's trichrome staining to visualize the collagen content ( Figure 1 ).
Both cell density and cell size differed statistically significantly between tumor types. The highest cell density was found in LPB and SA-1 fibrosarcomas, somewhat lower in EAT mammary carcinoma, and the lowest in B16F1 melanoma. A statistically significant negative relationship existed between cell size and cell density. B16F1 melanoma was composed of the biggest Figure 1 Differences in histological properties between four tumors. LPB fibrosarcoma (a, e and i), SA-1 fibrosarcoma (b, f and j), EAT mammary carcinoma (c, g and k) and B16F1 melanoma (d, h and l) sections were prepared as described in Materials and Methods. Cell density and cell size of H&E-stained sections (a-d), dark violet-colored proteoglycans of PAS-stained sections (e-h) and blue-colored collagen of Masson's trichrome-stained sections (i-l) were evaluated under a transmission microscope equipped with a CCD camera. Bars are 50 mm. Arrows indicate proteoglycans and collagen. H&E, hematoxylin-eosin.
The effect of the histological properties of tumors S Mesojednik et al cells and LPB of the smallest. Furthermore, differences in cell shape were also observed. LPB and SA-1 fibrosarcoma cells have a more spindle-like shape, whereas EAT mammary carcinoma and B16F1 melanoma cells are more spherical. In contrast to cell size, the fraction of extracellular matrix did not correlate with cell density. In LPB tumors there was significantly more extracellular matrix than in the other three tumor types. In B16F1 melanoma, higher values of extracellular matrix area were obtained, as was expected on the basis of proteoglycan and collagen content. These could be partly due to the presence of adipocytes, which occupied B2% of the measured test area and were included in the calculation of the extracellular matrix area. In addition, the presence of fluids such as blood plasma or serum could also contribute to this observation (Figures 1 and 2 ). To analyze differences in proteoglycan and collagen content between the four tumor types, the areal density of proteoglycans and collagen was determined in 18 fields of view per tumor type using the M-100 multipurpose stereological test system. Areal densities of proteoglycans and collagen were normalized to the extracellular matrix area. The PAS-stained sections showed that LPB, SA-1 and EAT tumors had high proteoglycan content, whereas in B16F1 proteoglycans were observed only in trace amounts (Figures 1e-h and 3) . The mean fractional value of proteoglycans (0.20) did not differ between LPB, SA-1 and EAT tumors. In the Masson's trichrome-stained sections, the collagen content was at approximately the same level in LPB, SA-1 and EAT (B0.20). In the LPB and SA-1 fibrosarcomas, intense staining for collagen with apparently wellorganized collagen lattices was observed, whereas collagen organization was not evident in EAT mammary carcinoma. Furthermore, only traces of collagen were found in B16F1 melanoma, and the mean fractional value was statistically significantly lower compared to the other three tumor types (Figures 1i-l and 3 ).
In addition, tumor samples were checked for the presence of necrosis and immune cells. Neither necrosis nor infiltration of immune cells was observed in histological samples from any tumor type.
Transfection efficacy of electrically assisted gene delivery in solid tumors
The importance of the time interval between DNA injection and subsequent electroporation of tumors for effective electrically assisted gene delivery was already The effect of the histological properties of tumors S Mesojednik et al demonstrated in our previous study, which indicated that it is tumor type dependent. 33 Namely, in tumors with higher cell density and high proteoglycan and collagen content, the penetration of plasmid DNA should be slower; thus, longer time intervals between DNA injection and electroporation are needed for achieving optimal transfection efficiency. Therefore, to confirm the effect of histological properties on DNA distribution in different tumors and consequently on the transfection efficiency of electrogene transfer, different time intervals were tested between DNA injection and the subsequent electroporation of tumors.
Solid tumors were treated with intratumoral injection of plasmid pCMVLuc or pEGFP-N1 and then electroporated at different time intervals (0.5, 5, 10, 15, 30 and 60 min) after plasmid DNA injection. The levels of luciferase and green fluorescent protein (GFP) expression were significantly higher in B16F1 melanoma and EAT mammary carcinoma tumors, compared to both LPB and SA-1 fibrosarcoma tumors, at any time interval tested (Figures 4 and 5) .
The optimal time interval between DNA injection and electroporation for achieving the highest transfection efficiency varied depending on the tumor type. Significantly increased luciferase activity was detected in B16F1 melanoma if plasmid DNA was injected between 5 and 15 min before electroporation. Similar results were obtained in the case of EAT mammary carcinoma, with significantly improved transfection detected at the time intervals 10 and 15 min. In LPB and SA-1 tumors, the highest luciferase activity was obtained when plasmid DNA was injected 10 or 15 min before electroporation of tumors. However, statistical analysis showed no significant difference between any of the time intervals tested for LPB and SA-1 tumors (Figure 4) . The large error bars in the figure demonstrate high tumor heterogeneity and variability. 10 In addition, error bars in the groups treated with application of electric pulses were smaller than error bars in the control group. 34 The results on GFP expression confirmed the results on luciferase activity in tumors, demonstrating that the highest GFP expression was obtained in B16F1 melanoma and much lower in both fibrosarcomas ( Figure 5 ). Increased levels of GFP expression were observed in all four tumor types at 5-15 min time intervals between DNA injection and subsequent electroporation. At these time intervals, GFP was observed both at the periphery and in the center of tumor sections. Outside the optimal time window, where lower transfection efficiencies were obtained, GFP was detected only at the periphery of tumor sections ( Figure 5 ). Specifically, in B16F1 melanoma, where the highest transfection efficiency was obtained, GFP was distributed throughout the tumor section ( Figure 5 ). These results indicate that an optimal time interval between DNA injection and electroporation of tumors for achieving pronounced transfection efficiencies exists for soft, low cell density tumor types with larger cells (B16F1 and EAT), as compared to rigid, high cell density tumor types with smaller cells (LPB and SA-1), where transfection efficiency was not dependent on the time interval between DNA injection and electroporation. Furthermore, Pearson correlation statistics showed a significant relationship (Po0.05) between the cell number or cell size and transfection efficiencies at time intervals from 0.5 to 10 min, as well as between proteoglycan and collagen content and transfection efficiencies at the 5 min time interval among the four tumor types.
Discussion
In this study, we have shown that the histological properties of tumors, such as cell density, cell size, and proteoglycan and collagen content, influence the transfection efficiency of electrically assisted gene delivery to tumors. The examined histological properties correlated statistically significantly with transfection efficiency at shorter time intervals between DNA injection and electroporation (0.5-10 min). We demonstrated that in tumors with large cells and low cell density, there exists a narrow optimal time interval between DNA injection and electroporation, during which pronounced transfection efficiency occurs. In contrast, for tumors with small cell size and high cell density, there is no optimal time interval and transfection occurs regardless of time between DNA injection and electroporation of tumors. However, the transfection efficiency in high cell density tumors with small cell size (LPB and SA-1) was much lower compared to tumors with low cell density and larger cells (B16F1 and EAT). In addition, we showed that proteoglycan and collagen content, which affects DNA distribution in tumors, might have an effect on transfection efficiency as demonstrated by the high correlation coefficient at the 5 min time interval, but this effect was less pronounced compared to other histological properties.
The effects of tumor cell size, cell shape and cell density on the electropermeabilization of cells and consequently on the transfection efficiency of electrically assisted gene delivery have already been studied by mathematical modeling and in vitro cell electroporation experiments. 21, 31, 32, 35, 36 Theoretical models and in vitro experimental results showed that permeabilization is not only a function of electric field intensity and cell size, but also of cell shape and orientation, as well as cell density and cell organization within a specific model of multicellular structure. It was demonstrated that with increased cell size, a lower field strength is required for membrane electroporation and subsequent DNA uptake. 36 Dependence on cell orientation (cell shape) is more pronounced for elongated cells (spindle-like cells), whereas it is negligible for spherical cells. 31, 35 The results of our study confirmed the in vitro results and extended them to solid tumors in vivo. Utilization of the same electric pulse parameters resulted in much higher transfection efficiencies in B16F1 melanoma tumors, having the largest and the most spherical cells, and EAT mammary carcinoma tumors with slightly smaller spherical cells, as compared to LPB or SA-1 fibrosarcoma tumors with smaller cell size and spindlelike cell shape.
Furthermore, mathematical models, as well as study on tumor spheroids suggested that a multicellular environment decreased the effects of electroporation on cell membrane permeability, and these effects varied inversely with the number of cells around a given cell. Therefore, a multicellular environment resulted in a reduced uptake of molecules into the cells. 21, 32 These results support the results of our present and previous in vivo studies on solid tumors, where cell density correlated with transfection efficiency. 7, 33 Low levels of luciferase or GFP expression were found in high cell density LPB and SA-1 fibrosarcomas, whereas high levels were found in the low cell density B16F1 melanoma and EAT mammary carcinoma.
Another factor that might affect DNA distribution in tumors and eventually the uptake of DNA into tumor cells by determining the transport properties of plasmid DNA injected into tumors is the composition, structure and area of the extracellular matrix in tumors. 2 As demonstrated for anticancer drugs, as well as for high molecular weight immunoglobulins, the extracellular matrix represents a so-called 'physiological resistance' to treatment. [22] [23] [24] [25] [26] [28] [29] [30] Especially in the case of immunotherapy and gene therapy, where high molecular weight molecules have to reach tumor cells, the effectiveness of treatment can be seriously reduced owing to the failure of molecules to penetrate the extracellular matrix of tumors. In the case of electrically assisted gene delivery, physiological resistance can be reduced in part by inducing an electric field in tumors, which can facilitate DNA distribution. Zaharoff et al. 20 showed that the average plasmid DNA movements via a pulsed electric field were 4.2-fold farther in B16F1 melanoma than 4T1 sarcoma. Plasmid DNA mobility was correlated with tumor collagen content, which was approximately eight times greater in 4T1 than in B16F1 tumors. This is in agreement with the results of our study, where histological analysis of tumors showed two to three times greater proteoglycan and collagen content in fibrosarcomas than in B16F1 melanoma. Differences in extracellular matrix composition translated into differences in transfection efficiency, being the highest in B16F1 melanoma with the lowest proteoglycan and collagen content. However, other histological factors might play a role in hindering DNA diffusion through tumor tissue, such as proteins involved in cell-to-cell contacts, as well as other proteins of the extracellular matrix. To evaluate further and confirm the effect of the composition of the extracellular matrix on mobility and distribution of DNA in tumors, different time intervals between DNA injection and electroporation of tumors were tested to
The effect of the histological properties of tumors S Mesojednik et al demonstrate that DNA needs a longer time to distribute in high proteoglycan and collagen content tumors, compared to low proteoglycan and collagen content tumors. Although Zaharoff et al. 20 showed in tumor slices ex vivo that free diffusion of plasmid DNA is a very slow process and is facilitated by applying an external electric field, we demonstrated that free diffusion, at least in tumors with low collagen content, plays a role in achieving transgene expression. Namely, we found that B16F1 melanoma, with a low proteoglycan and collagen content, has higher transfection efficiencies achieved at shorter time intervals than the other three tumor types. These three tumor types should have the same DNA mobility, but due to differences in cell size, cell shape and cell density, electrically assisted gene delivery in EAT mammary carcinoma yielded better transfection efficiency. LPB and SA-1 fibrosarcomas with high proteoglycan and collagen content, high cell density, spindle-like cell shape and small cell size resulted in low transfection efficiencies at all tested time intervals between DNA injection and electroporation. To fully demonstrate different mobility and distribution of plasmid DNA in different tumor types, further studies using fluorescently labeled DNA should be performed.
In our study, when using the melanoma (B16F1) or carcinoma (EAT) tumor types with the largest cell size and lowest proteoglycan and collagen content, an increased level of luciferase expression was obtained only in a narrow time window (B5-15 min) between plasmid DNA injection and the application of electric pulses. As already indicated in our previous study, the results of this study also support the notion that the degradation of DNA in tumors compared to muscle tissue is a quicker process from both compartments of DNA in tissue -the one that is quickly degraded and cleared out, and the other electrotransferable one. 33 However, in the case of fibrosarcoma tumors there was no significant increase in the level of luciferase expression; this can be explained by poor distribution of DNA through compact tumor tissue, high proteoglycan and collagen content, and a too-low external electric field, resulting in a low proportion of permeabilized cells, predominantly in the middle plane of the tumor. Differences in time-dependent transfection efficiencies were also reflected in the expression level and spatial distribution of GFP. In LPB and SA-1 tumors, GFP was detected only at the periphery of the tumor sections, with the exception of the 10 min time interval, where GFP was visible in the middle of the tumor sections. In melanoma (B16F1) and carcinoma (EAT) tumors, higher transfection efficiencies were obtained and GFP was distributed throughout the whole tumor sections. However, if DNA was injected outside the optimal time window, lower transfection levels were obtained and GFP was detected only at the periphery of the tumor sections, as in LPB and SA-1 tumors. One might speculate that the effect of the time interval on transfection efficiency could be due to pressure of injection or needle penetration. However, in a recent study Andre et al. 37 showed that there is no statistically significant difference in transfection efficiency of tumors when using slow or fast injection (low or high pressure). This indicates that the influence of time interval on transfection efficiency cannot be linked to the damage caused by needle penetration or pressure of injection, but is rather due in large part to plasmid DNA diffusion.
Finally, the unique biological properties of different tumor types, fibrosarcoma, mammary carcinoma and melanoma may also be responsible for differences in transfection efficiency. It is well known that tumors are biologically heterogeneous systems with differences in growth rate and architecture, antigenicity, immunogenicity, morphology, histology, genotype and biochemical properties (such as the presence of DNases in tumors). Differences regarding tumor type sensitivity to chemotherapeutic agents and ability to express transgenes has also been well documented; the reason for this phenomenon might lie in the variable biological properties. 38 Furthermore, plasmid DNA characteristics can also affect transgene expression. The main properties of plasmid DNA that can influence transgene expression are volume, size of the injected plasmid DNA, type of promoter (constitutive vs inducible, tissue specific), and presence of CpGs. 2, 39, 40 In our case, cytomegalovirus (CMV) promoter was used in all experiments. Although CMV promoter is a strong promoter, we cannot rule out that the relative level of reporter expression may depend on cell type transcription in response to the CMV promoter. However, this should not affect the time course of transfection within each tumor type.
So far the major determinants of tumor heterogeneity responsible for different levels of electrogene transfection efficiency have not been well defined. In this study as well as in our previous one, we propose that electrogene transfection efficiency is at least in part dependent on tumor type. Namely, we found that the highest transfection efficiency was obtained in melanoma (B16F1), followed by carcinomas (EAT and T24), with the lowest transfection efficiency obtained in sarcomas or carcinosarcoma (LPB, SA-1, SaF and P22). 7, 33 Exactly which biological properties of cells in solid tumors contribute to differences in transfection efficiency (besides the already known physical parameters of applied electric pulses and histological properties of tissues) are as yet unknown, but molecular biology techniques such as genomics and proteomics could provide an answer to this question.
Collectively, the results of our study point out the importance of the histological properties of tumors for effective electrogene therapy. Specifically, this is important for tumors that possess unique characteristics, attributed in part to an embryonic-like stage of their development with an extensive synthesis of extracellular matrix, leading to substantial differences in composition and assembly compared to the host tissue. Tumors with larger spherical cells, low cell density and low proteoglycan and collagen content are more effectively transfected than high proteoglycan and collagen content tumors with small spindle-shaped cells of high density. Furthermore, in those tumors that had larger, spherical cells, an optimal time interval for transfection does exist. Regardless, knowledge about the histology of tumors can assist in planning electrogene therapy in a clinical setting, 3 with respect to the time interval between DNA injection and electroporation, as well as the selection of electrical parameters to obtain sufficient electric field distribution in tumors. In the experiments female C57Bl/6, CBA and A/J mice purchased from the Institute of Pathology (Medical Faculty, University of Ljubljana, Slovenia) were used. At the beginning of the experiments, animals were 10-12 weeks old. Mice were kept in a conventional animal colony at a constant room temperature (211C) and a natural day/night light cycle. Food and water were provided ad libitum. Animals were subjected to an adaptation period of 7-10 days before experiments.
In this study, four different murine tumor cell lines were used: SA-1 fibrosarcoma syngeneic to A/J mice, LPB fibrosarcoma (a clonal derivate of TBL.C12) and B16F1 melanoma (CLR6323; American Type Culture Collection, Manassas, VA, USA) syngeneic to C57B1/6 mice, and EAT mammary carcinoma syngeneic to CBA mice. LPB and B16F1 cells were routinely maintained in Eagle's minimal essential medium (Sigma Chemical Co., St Louis, MO, USA) supplemented with 10% fetal calf serum (Sigma) and antibiotics in a humidified atmosphere at 371C, containing 5% CO EAT and 1.0 Â 10 6 B16F1 cells in 0.1 ml of 0.9% NaCl) were injected subcutaneously to obtain tumors of 6 mm in diameter in approximately 8-12 days. During this period of time, no tumor necrosis was observed. After tumors reached the desired size (approximately 6 mm in diameter), the animals were randomly divided into experimental groups and subjected to specific experimental protocols.
Determination of the composition and structure of tumor interstitial matrix, cell size, cell density, necrosis and immune cell infiltration Histological analysis for proteoglycan and collagen content, cell density and cell size was performed on subcutaneous tumors of 6 mm in diameter. Tumors were excised, cut into two pieces along the largest diameter, and fixed in buffered formalin. The tumors were then embedded in paraffin, cut into 5 mm sections and stained with Masson's trichrome for collagen, PAS for proteoglycans, and H&E for cell density estimation. Tumor slides were observed by transmission microscopy with a Â 60 objective, and images were taken by CCD camera DP70 (Olympus, Hamburg, Germany). In H&E-stained tumor sections, tumor necrosis, macrophage and lymphocyte infiltration, as well as the number and size of cells in the microscopic fields, were determined for each tumor type by using DP Soft (Olympus). Three fields were scored per section and six tumors were used per tumor type. Cell density was determined as average number of cells per field and expressed as number of cells per mm 2 , cell size was determined by measuring cell diameter of cells in the field. The longest diameter of the cells was used to determine the cell size. To determine proteoglycan and collagen content in the tumors, the M-100 multipurpose test system was used. Areal density of proteoglycans and collagen was estimated in each tumor slide.
Plasmids
Plasmids pEGFP-N1 (encoding GFP; Clontech, Basingstoke, UK) and pCMVLuc (encoding luciferase, kind gift from Dr Lluis M Mir, Institute Gustave Roussy, France) were prepared using the EndoFree Plasmid Maxi Kit (Qiagen, Hilden, Germany), according to manufacturer's instructions and diluted in H 2 O to a concentration of 1 mg/ml.
Tumor transfection protocol
Electrically assisted gene delivery was performed by intratumoral injection of plasmid DNA (50 ml/tumor) with subsequent electroporation of the tumor. The procedure involving intratumoral injection lasted B10-15 s, and included both injection of the plasmid and retention of the needle in the tumor for few seconds to prevent leakage of the solution. Injections were made using an insulin syringe with a very thin needle of 28 G. All the injections were made by one person to avoid interpersonal variability, and the speed of injection was controlled manually. Electric pulses were delivered through two parallel stainless steel electrodes with 6 mm distance between them. Eight square-wave electric pulses were delivered in two sets of four pulses in perpendicular directions at a frequency of 1 Hz, amplitude over distance ratio 600 V/cm and 5 ms duration. This amplitude over distance ratio was chosen on the basis of in vitro as well as in vivo results, demonstrating that at this amplitude a plateau of transgene expression level was obtained in different tumor types. 6, 7, 10 Furthermore, higher amplitudes could also lead to irreversible electrical injuries. Good contact between electrodes and the overlying skin was assured by hair clipping and use of a conductive gel. Electric pulses were generated by electroporator Jouan GHT 1287 (Jouan, St Herblain, France). Electrodes were placed percutaneously at opposite margins of the tumor. Experimental groups differed in the time interval between plasmid DNA injection and application of electric pulses (from 1 h to 0.5 min). Control groups received only intratumoral injection of plasmid DNA without application of electric pulses. Tumors were excised 48 h post-transfection, as the level of gene expression reaches a plateau between 24 and 48 h, which has already been determined in in vitro as well as in vivo studies in different tumor cell types. 4, 41 Groups consisted of six tumors per group if treated with pCMVLuc or three tumors per group if treated with pEGFP-N1. Experiments were repeated two to three times.
Transfection efficiency assessment
Tumors treated with plasmid pCMVLuc were weighed, immediately frozen in liquid nitrogen and stored at À801C until further procedures. Thawed tumors were homogenized in 1 ml of Glo Lysis Reagent (Promega,
The effect of the histological properties of tumors S Mesojednik et al Madison, WI, USA) using sonificator UP200 H (Dr Hielscher, Teltow, Germany). Thereafter the samples were centrifuged at 10000 g for 10 min and the supernatant stored at À801C. Luciferase activity was measured in thawed supernatants using Genios luminometer (Tecan, Zurich, Switzerland). Photoemission was measured during a 5 s period after 5 min incubation at room temperature of 100 ml tumor cell lysate and 100 ml Luciferase Assay Substrate (Promega). Luciferase activity was quantified as relative light units and then converted to pg luciferase/mg tumor tissue, using the pre-prepared calibration curve of known quantities of luciferase (Promega).
Tumors treated with plasmid pEGFP-N1 were embedded in Tissue-Tek OCT Compound (Miles Inc., Elkhart, IN, USA) and stored at À201C for subsequent processing. Cryosections of 20 mm at different depths of tumor (24 sections per tumor) were cut for analysis. Transfection efficiency and spatial distribution of GFP was estimated in frozen tumor sections using fluorescence microscope BX51 equipped with a DP70 CCD camera (Olympus).
Statistical analysis
The data were tested for normality of distribution using the Kolmogorov-Smirnov test. Differences between experimental groups were statistically evaluated by one-way analysis of variance followed by the HolmSidak test for multiple comparisons. Correlation between histological properties and transfection efficiency with regard to the time interval between DNA injection and electroporation was determined by Pearson's correlation statistics. A P-value of less than 0.05 was considered to be statistically significant. Statistical analysis was done using Sigma Stat (SPSS Inc., Chicago, IN, USA) software.
